disease

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series

by
OSU Wexner Medical Center logo

Learn About Clinician Approaches to Tobacco Cessation on Webcast Series.  Participants will gain an understanding of evidence-based strategies to support patients in quitting tobacco including behavioral interventions and pharmacotherapy options. Actuarily, on average, a woman who smokes a pack of cigarettes a day will live 11 years less than a woman who doesn’t smoke. Men who smoke a pack a day live 12 years less than non-smoking men. If you do the math, that works out to 14 minutes of life lost for every cigarette a person smokes. It’s a childhood epidemic with 90% of smokers beginning before age 18. By the time they are adults, they are fully addicted and quitting becomes very hard because of the severity of nicotine withdrawal symptoms.   But the good news is that we can help ameliorate those symptoms to help patients quit their nicotine habits.

Joining us today are two of the Ohio State University’s tobacco cessation experts. Lindsey Lee is a clinical pharmacist in the Division of General Internal Medicine. And Suzanne Higginbotham is also a clinical pharmacist in the Division of General Internal Medicine.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the health impacts of tobacco use
  • Apply evidence-based cessation strategies and interventions for nicotine dependence
  • Implement appropriate treatment and follow up protocols to enhance patient adherence and reduce relapse

You’ll also learn about the following:

  • Nicotine dependence tests
  • The pharmacist’s role in tobacco cessation
  • Nicotine replacement strategies for the heavy smoker
  • Cytisinicline (cytisine)
  • Pharmacologic approach to inpatients who are smokers
  • Pharmacologic approach to the smoker with coronary artery disease
  • Tobacco cessation and adolescents
  • Weight gain and tobacco cessation
  • E-cigarettes and tobacco cessation
  • Cough increase in the short-term after smoking cessation
  • Tobacco cessation in the habitual marijuana smoker
  • Over the counter pharmacologic therapies
  • Pharmacist prescriptive authority

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Learners About Alzheimer’s Disease

by
OSU Wexner Medical Center logo

CME Webcast Teaches Learners About Alzheimer’s Disease.  Expert Teaches on Artificial Intelligence in Medicine. This program will discuss Alzheimer’s Disease.  This webcast will discuss new developments in our understanding of the pathogenesis and diagnosis of Alzheimer’s Disease. In addition, this webcast will review new treatments for Alzheimer’s Disease, including anti-amyloid monoclonal antibodies.

For more than a century, there was little physicians could do for patients with Alzheimer’s Disease other than diagnose it and provide supportive care. But during the past 2 years, new drugs have been approved by the FDA that appear to actually modify the progression of the disease. On this webcast, we’re going to update you on Alzheimer’s Disease. Joining us is Assistant Professor of Neurology, Dr. Arun Ramamurthy.

What you’ll learn on this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe Alzheimer’s Disease pathology
  • Discuss current medication options
  • Highlight Alzheimer’s Biomarkers
  • Future directions in diagnosis and treatment

You’ll also learn about the following:

  • Diagnosis of Alzheimer’s Disease
  • Treatment of Alzheimer’s Disease

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Learn Latest on Sickle Cell Disease on Webcast

by
OSU Wexner Medical Center logo

Learn Latest on Sickle Cell Disease on Webcast. This program will go through the challenges for people with sickle cell disease to obtain primary care, especially the challenges around the transition from pediatric to adult care. Learners will also learn about preventative, acute, and chronic care topics important for primary care physicians caring for individuals with sickle cell disease. The second half of the program will go over the pathophysiology of sickle cell disease, disease modifying treatments, and management of chronic pain.

For this webcast, we’ve invited two experts to discuss modern care of patients with Sickle Cell Disease with an emphasis on primary care. First, Dr. Rob Cronin is an Associate Professor of Internal Medicine & Pediatrics and is a clinician scientist who not only provides primary care for patients with sickle cell disease.  He also uses his clinical informatics training to study topics including sickle cell disease, disparities, and transitions from pediatric to adult centered care. Our second presenter is Dr. Andrew Schamess. Andrew is an Associate Professor of Internal Medicine who has helped create a novel home-based primary care program for patients with sickle cell disease.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Describe preventive care for people with SCD, including nuances for this population
  • Describe some common acute and chronic issues in SCD that intersect with primary care and how to manage them
  • Identify three disease modifying agents that are used to treat sickle cell disease.
  • Identify three factors that can contribute to chronic pain in adults with sickle cell disease.
  • You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.

Webcast Teaches Physicians About Advances in Liver Disease

by

OSU Wexner Medical Center logo Webcast Teaches Physicians About Advances in Liver Disease. Last summer, experts from around the world worked together to rename Nonalcoholic fatty liver disease into Metabolic dysfunction-associated steatotic liver disease or MASLD. And earlier this year at the end of March 2024, the FDA approved the first drug to treat MASLD. Meanwhile another promising agent is already in the pipeline, currently undergoing phase 3 clinical trials.

To share more about the advances in some of the most common liver conditions including MASLD, autoimmune hepatitis, and Hepatocellular carcinoma, We’ve invited one of Ohio State University’s Transplant Hepatology experts. We are pleased to introduce Assistant Professor of Gastroenterology and Hepatology Dr Vivek Mendiratta.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand steatotic liver disease including diagnosis, management, and pharmacologic treatment options.
  • Learn about the newest advances in hepatocellular carcinoma including the role of combination therapy, novel biomarkers, and liver transplantation.

You’ll also learn about the following:

  • Treatment & Monitoring
  • Weight Loss
  • Liver Transplantation

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches on Emerging Approaches in Parkinson’s Disease

by
OSU Wexner Medical Center logo

CME Webcast Teaches on Emerging Approaches in Parkinson’s Disease. There is no cure for Parkinson’s disease. Yet, there is reason for hope. In recent years, groundbreaking research has propelled us closer to understanding the underlying mechanisms of the condition and developing more effective treatments. From deep brain stimulation to innovative pharmacological interventions, the future of Parkinson’s care is brighter than ever before.

To discuss the new developments in Parkinson’s Disease care, we’ve have invited an expert from Ohio State University Wexner Medical Center’s Center for Parkinson’s Disease. We are pleased to introduce Assistant Professor of Neurology Dr. Zachary Jordan. Zach is fellowship trained in movement disorders and specializes in the care of Parkinson’s Disease.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the basic approach to medical management of motor symptoms in Parkinson’s disease
  • Recognize motor complications and the strategies that exist to address them

You’ll also learn about the following:

  • Prevalence
  • Prognosis
  • Dosing
  • Adjuvant Therapies
  • Advance Care Planning
  • Treatment Side Effects
  • Cognitive Dysfunction
You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual.  You can also e-mail him at derrick.freeman@osumc.edu.